Autolus Therapeutics is a biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. The Company is committed to bringing life-changing treatments to cancer patients by reprogramming their own T-cells to more effectively combat the treatment of hematological malignancies and solid tumors.